Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Clin Cancer Res. 2018 May 16;24(17):4098–4109. doi: 10.1158/1078-0432.CCR-18-0449

Table 2.

Infections pre- and post-aDLI

Patient aDLI
dose/day
CMV
IgG
(D/R)
Pre-aDLI Post-aDLI
Bacterial Infection Viral Reactivation Viral Infn Fungal Infn Viral Reactivation Viral Infn Fungal Infn
001 Level 1, D+35 −/− None None None None VZV skin D+76 None None
002 Level 1, D+35 +/− Stomatococcua blood D+1 BK urine D-8 None None EBV blood D+147,BK urine D+49,254,331, VZV skin D+260 EBV D+147
VZV D+260
None
003 Level 1, D+35 −/+ E.Coli blood D-3
VRE blood D0
HSV oral D+28
CMV blood D+33
HSV D+28 None None None None
004 Level 1, D+42 +/+ Enterobact. blood D-6
Proteus Urine D+32
BK urine D+5, CMV blood D+26, RSV NP D+26 RSV D+26 None EBV blood D+234 None None
005 Level 2, D+42 +/+ None None None None RSV NP D+209 RSV D+209 None
010 Level 2, D+34 +/+ Staph Epi blood D-8 CMV blood D+20,30 None None CMV blood D+74,84,96, HHV6 BM D+78 None None
012 Level 2, D+35 −/+ C.Diff colitis D-2 CMV blood D+20 None None None None None
013 None given −/+ Stomatococcus + VRE blood D+11 N/E N/E N/E N/E N/E N/E
025 None given§ +/+ Corynebacterium blood D+27 HSV nasal D+24
CMV blood D+27
HSV nasal D+24 N/E N/E N/E
026 Level 2, D+35 −/+ None None None None None None None
027 Level 2, D+42 +/+ None CMV blood D+16 None Aspergillus BAL D+13 CMV blood ends D+73 then reactivates D+209 CMV retinitis D+114 to D+176 None
028 || None Given +/+ Fusobact + α-haem strep blood D+11 N/E N/E N/E N/E N/E N/E
030 Level 2, D+42 −/+ Staph Epi blood D-1 HSV oral D+35 HSV oral None None None None
033 Level 2, D+35 +/+ None BK urine D+13 None None BK blood D+53, EBV blood D+137. CMV blood D+179 None None
035 Level 2, D+35 +/+ VRE blood D+3 CMV blood D+23 None None None None Presumed fungal pneumonia D+62
015 Level 3, D+36 +/− α-haem strep blood D+1, C.Diff colitis D+8 None None None EBV blood D+124 EBV D+124 None
016 Level 3, D+35 +/+ α-haem strep blood D+1 BK urine D+13, CMV blood D+27 None None CMV blood D+106, cleared after D+141 None Aspergillus pneumonia D+172
018 Level 3, D+35 −/− None Adeno blood, urine, stool D+18 BK urine D+25 Adenov. None Adenovirus (cleared by D+73) None None
023 Level 3, D+35 +/+ VRE Blood D+5 CMV blood D+24 None None BK blood D+76, Adenovirus urine, stool, sputum D+106 None Aspergillus in BAL D+96

Level 1, 103 CD3 T-cells/Kg, Level 2 104 CD3 T-cells/kg, Level 3, 105 CD3 T-cells/kg; D, donor; R, recipient; BKV, BK virus, VRE, vancomycin-resistant enterococcus; HSV, herpes simplex virus; RSV, respiratory syncytial virus; CMV, cytomegalovirus; C Diff, clostridium difficile; BAL; Bronch-alveolar lavage,

died D+32 of bacterial sepsis prior to infusion of aDLI.

§

Donor not able to donate.

||

non-engraftment followed by autologous reconstitutiion